CLINICAL_TRIALS
trial_result
· 2016-05-17
Clinical Trial Update: A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor [Phase 2]
Summary
Phase 2 clinical trial update evaluating ponatinib in metastatic and/or unresectable gastrointestinal stromal tumor; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ariad Pharmaceuticals | Conditions: GIST | Phase 2 | Status: COMPLETED | Results posted: 2016-05-17